Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.45 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.42 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.40 |
| ▸ | CXCR5 | P32302 | 1/20 | 0.40 |
| ▸ | APLNR | P35414 | 1/20 | 0.40 |
| ▸ | CCR6 | P51684 | 1/20 | 0.40 |
| ▸ | GFER | P55789 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28102125 | 0.82 | TSHR (0.52) | KMT2ATXNRD1SMN1; SMN2MEN1ALDH1A1 | |
| SCHEMBL4728735 | 0.81 | HTR6 (0.48) | NISCHKMT2ATXNRD1RAB9AAKR1B1 | |
| SCHEMBL4730459 | 0.79 | TXNRD1 (0.39) | TXNRD1CA1CA2 | |
| SCHEMBL28102213 | 0.78 | KMT2A (0.51) | KMT2ATXNRD1RAB9ANPC1SMN1; SMN2 | |
| SCHEMBL5755255 | 0.78 | CA1 (0.46) | TXNRD1SMN1; SMN2MAPTCA12CA1 | |
| SCHEMBL502541 | 0.78 | TXNRD1 (0.44) | NISCHTXNRD1RAB9ANPC1SMN1; SMN2 | |
| SCHEMBL14419315 | 0.78 | TXNRD1 (0.40) | GAAKMT2ATXNRD1RAB9ANPC1 | |
| Bromide SCHEMBL28322202 | 0.76 | TXNRD1 (0.43) | NISCHTXNRD1SMN1; SMN2ALDH1A1CA1 | |
| Hydrochloric Acid SCHEMBL28102214 | 0.76 | TXNRD1 (0.49) | KMT2ATXNRD1RAB9ANPC1SMN1; SMN2 | |
| SCHEMBL12998293 | 0.75 | NISCH (0.42) | NISCHKMT2ATXNRD1RAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 279 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119978514-B | PVC foaming regulator and preparation process thereof | 山东和天下新材料有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-119505858-B | High-performance water-based fracturing fluid and preparation method thereof | 陕西隆誉国际科技集团有限公司 | 2025-05-16 | — | — | CN | claimed |
| CN-119977852-A | Synthesis method of 2-methylsulfonyl-4-trifluoromethyl benzoic acid | 山东极地医药科技有限公司 | 2025-05-13 | — | — | CN | claimed |
| CN-119978514-A | PVC foaming regulator and preparation process thereof | 山东和天下新材料有限公司 | 2025-05-13 | — | — | CN | claimed |
| CN-119505858-A | High-performance water-based fracturing fluid and preparation method thereof | 陕西隆誉国际科技集团有限公司 | 2025-02-25 | — | — | CN | claimed |
| CN-117317221-A | High-first-efficiency high-power hard carbon negative electrode material and preparation method thereof | 安徽天宏基科技有限公司 | 2023-12-29 | — | — | CN | claimed |
| CN-112661725-B | Synthetic method of sex pheromone of fall webworm | 江苏宁录科技股份有限公司 | 2022-11-15 | — | — | CN | claimed |
| CN-111548356-B | Process for preparing tert-butyl-1, 8-dioxa-4, 11-diazaspiro [5.6] dodecane-11-carboxylic acid ester | 无锡合全药业有限公司 | 2022-05-17 | — | — | CN | claimed |
| CN-112661725-A | Synthetic method of sex pheromone of fall webworm | 江苏宁录科技股份有限公司 | 2021-04-16 | — | — | CN | claimed |
| CN-107915770-B | Antibody drug conjugate intermediate and preparation method thereof | 联宁（苏州）生物制药有限公司 | 2020-08-25 | — | — | CN | claimed |
| US-20120115962-A1 | CYCLODEXTRIN-MODIFIED POLYAMINES FOR DELIVERY OF THERAPEUTIC MOLECULES | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2012-05-10 | — | — | US | claimed |
| EP-1778778-A2 | ORGANOMETALLIC COMPOSITIONS AND COATING COMPOSITIONS | King Industries, Inc. (US) | 2007-05-02 | — | — | EP | claimed |
| WO-2006022899-A2 | ORGANOMETALLIC COMPOSITIONS AND COATING COMPOSITIONS | KING INDUSTRIES, INC. (US) | 2006-03-02 | — | — | WO | claimed |
| US-20050272934-A1 | Process for the synthesis of thalidomide | ANTIBIOTICOS S.P.A. (IT) | 2005-12-08 | — | — | US | claimed |
| EP-1602654-A1 | Process for the synthesis of thalidomide | Antibioticos S.p.A. (IT) | 2005-12-07 | — | — | EP | claimed |
| EP-0061761-B1 | A METHOD FOR PREPARING A MONONUCLEOTIDE-3'-PHOSPHODIESTER-BASED SUBSTRATE | Baker Instruments Corporation (US) | 1988-05-18 | — | — | EP | claimed |
| EP-0061760-B1 | A METHOD FOR PREPARING A MONONUCLEOTIDE-3'-PHOSPHODIESTER-BASED SUBSTRATE | Baker Instruments Corporation (US) | 1988-03-02 | — | — | EP | claimed |
| US-4529796-A | Method for making chromogenic and/or fluorogenic substrates for use in monitoring catalytic or enzymatic activity | BAKER INSTRUMENTS CORPORATION (US) | 1985-07-16 | — | — | US | claimed |
| EP-0061761-A1 | A method for preparing a mononucleotide-3'-phosphodiester-based substrate | Baker Instruments Corporation (US) | 1982-10-06 | — | — | EP | claimed |
| EP-0061760-A1 | A method for preparing a mononucleotide-3'-phosphodiester-based substrate | Baker Instruments Corporation (US) | 1982-10-06 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050272934-A1 | Process for the synthesis of thalidomide | QPCT, GLUL, QPCTL | GAA 386/4885NISCH 254/4885KMT2A 160/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.